2.42
Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten
ReShape Lifesciences boosts stockholders’ equity above Nasdaq minimum - Investing.com
ReShape Lifesciences Raises Equity to Avoid Delisting - TipRanks
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ReShape Lifesciences signs distribution deal with Recon Supply By Investing.com - Investing.com Canada
ReShape Lifesciences (RSLS) Stock Skyrockets Over 30% in Highly Volatile Session - Daily Chhattisgarh News
ReShape Lifesciences (RSLS) Signs Exclusive U.S. Distribution Deal | RSLS Stock News - GuruFocus
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets - GlobeNewswire
ReShape Secures Exclusive Distribution Rights to 18M Veteran Healthcare Market with Recon Supply Deal - Stock Titan
Global Weight-Loss Devices Market: Top Devices, Growth Factors - openPR.com
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - Asianet Newsable
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism By Stocktwits - Investing.com India
ReShape Lifesciences Prices $2.6 Million Share Offering - marketscreener.com
Crude Oil Moves Higher; Graham Shares Surge After Q4 Results - Benzinga
ReShape Lifesciences Announces Public Offering Pricing - TipRanks
ReShape Lifesciences prices public stock offering By Investing.com - Investing.com South Africa
ReShape Lifesciences prices public stock offering - Investing.com
SEC Form 424B5 filed by ReShape Lifesciences Inc. - Quantisnow
ReShape Lifesciences sets share price at $2.50 in public offering By Investing.com - Investing.com Canada
ReShape Lifesciences (RSLS) Announces Public Offering Pricing | - GuruFocus
Why Is ReShape Lifesciences Stock (RSLS) Down 45% Today? - TipRanks
ReShape Lifesciences (RSLS) Announces Public Offering Pricing | RSLS Stock News - GuruFocus
ReShape Lifesciences® Announces Pricing of Public Offering of Common Stock Raising Approximately $2.6 Million - Nasdaq
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering - GlobeNewswire
ReShape Lifesciences Prices 1M Share Public Offering at $2.50 Per Share, Raising $2.6M for Weight Loss Solutions - Stock Titan
Reshape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - MENAFN.com
Small Cap Stocks To Keep An Eye OnJune 3rd - MarketBeat
SEC Form 424B3 filed by ReShape Lifesciences Inc. - Quantisnow
ReShape Lifesciences achieves EU and UK medical device certification By Investing.com - Investing.com South Africa
ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuation - Asianet Newsable
Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge - Benzinga
ReShape Lifesciences Receives EU Certification for Product Portfolio; Shares Jump - marketscreener.com
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuation By Stocktwits - Investing.com India
ReShape Lifesciences (RSLS) Stock Skyrockets Over 62% in Morning Trading Frenzy - Daily Chhattisgarh News
ReShape Lifesciences (RSLS) Achieves Key European and UK Certifications | RSLS Stock News - GuruFocus
ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio - The Manila Times
ReShape Lifesciences Achieves EU MDR and UKCA Certification for Medical Devices, Enhancing Patient Safety and Market Access in Europe - Nasdaq
ReShape Lifesciences achieves EU and UK medical device certification - Investing.com
ReShape Lifesciences Beats 2027 Deadline: Gains Crucial EU MDR Certification While Others Still Wait - Stock Titan
RSLS stock touches 52-week low at $4.03 amid market challenges By Investing.com - Investing.com South Africa
RSLS stock touches 52-week low at $4.03 amid market challenges - Investing.com India
ReShape Lifesciences Faces Nasdaq Delisting Notice - TipRanks
ReShape Lifesciences Announces Equity Distribution Agreement - TipRanks
ReShape Lifesciences announces merger progress By Investing.com - Investing.com South Africa
ReShape Lifesciences Announces Merger with Vyome Therapeutics - TipRanks
ReShape Lifesciences announces merger progress - Investing.com
ReShape Lifesciences (NASDAQ:RSLS) Raised to Hold at Wall Street Zen - Defense World
ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update - GlobeNewswire
RSLS stock touches 52-week low at $5.5 amid market challenges - Investing.com
ReShape Lifesciences reports Q1 EPS $18.98 vs. ($135.37) last year - TipRanks
ReShape Lifesciences (RSLS) Reports Q1 Revenue Drop and Highlights Strategic Advances | RSLS Stock News - GuruFocus
ReShape Lifesciences Inc. Reports First Quarter 2025 Financial Results and Strategic Updates - Nasdaq
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):